X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PANACEA BIOTECH DR. DATSONS LABS/
PANACEA BIOTECH
 
P/E (TTM) x -10.9 -7.1 - View Chart
P/BV x 0.2 2.3 7.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   PANACEA BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PANACEA BIOTECH
Mar-14
DR. DATSONS LABS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs126149 84.5%   
Low Rs3182 37.5%   
Sales per share (Unadj.) Rs133.084.1 158.1%  
Earnings per share (Unadj.) Rs0.2-18.3 -0.8%  
Cash flow per share (Unadj.) Rs6.6-6.7 -98.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.883.7 153.9%  
Shares outstanding (eoy) m31.6661.25 51.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.4 42.9%   
Avg P/E ratio x516.1-6.3 -8,180.6%  
P/CF ratio (eoy) x11.8-17.2 -68.7%  
Price / Book Value ratio x0.61.4 44.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4777,074 35.0%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m561,449 3.9%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m4,2115,154 81.7%  
Other income Rs m79100 78.9%   
Total revenues Rs m4,2895,254 81.6%   
Gross profit Rs m569-766 -74.2%  
Depreciation Rs m204711 28.7%   
Interest Rs m4301,503 28.6%   
Profit before tax Rs m13-2,881 -0.4%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-6 31.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m617 36.3%   
Profit after tax Rs m5-1,121 -0.4%  
Gross profit margin %13.5-14.9 -90.8%  
Effective tax rate %48.0-0.6 -8,235.4%   
Net profit margin %0.1-21.8 -0.5%  
BALANCE SHEET DATA
Current assets Rs m6,8523,810 179.8%   
Current liabilities Rs m6,7118,365 80.2%   
Net working cap to sales %3.3-88.4 -3.8%  
Current ratio x1.00.5 224.2%  
Inventory Days Days161156 103.3%  
Debtors Days Days31867 473.7%  
Net fixed assets Rs m3,67314,480 25.4%   
Share capital Rs m31761 516.5%   
"Free" reserves Rs m3,761903 416.5%   
Net worth Rs m4,0785,127 79.5%   
Long term debt Rs m1,6715,832 28.7%   
Total assets Rs m12,63319,433 65.0%  
Interest coverage x1.0-0.9 -112.3%   
Debt to equity ratio x0.41.1 36.0%  
Sales to assets ratio x0.30.3 125.7%   
Return on assets %3.42.0 175.3%  
Return on equity %0.1-21.9 -0.5%  
Return on capital %7.73.6 211.0%  
Exports to sales %22.924.5 93.4%   
Imports to sales %14.310.2 140.4%   
Exports (fob) Rs m9641,264 76.3%   
Imports (cif) Rs m602525 114.7%   
Fx inflow Rs m9641,539 62.6%   
Fx outflow Rs m607942 64.4%   
Net fx Rs m357597 59.8%   
CASH FLOW
From Operations Rs m1,345599 224.4%  
From Investments Rs m-2,256-438 515.1%  
From Financial Activity Rs m-1,200-303 396.5%  
Net Cashflow Rs m-2,111-141 1,493.8%  

Share Holding

Indian Promoters % 4.5 74.5 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 1.4 1.3 103.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.6 398.7%  
Shareholders   20,807 10,259 202.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS